Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots.

Journal of clinical microbiology - 1 Oct 2007

Steegen Kim, Luchters Stanley, Demecheleer Els, Dauwe Kenny, Mandaliya Kishor, Jaoko Walter, Plum Jean, Temmerman Marleen, Verhofstede Chris

Abstract excerpt

Due to high cost, availability of human immunodeficiency virus type 1 (HIV-1) drug resistance testing in resource-poor settings is still limited. We therefore evaluated the usefulness of viral DNA extracted from either whole blood or dried blood spots (DBS). Samples were collected from 50 patients receiving therapy and 10 therapy-naïve patients. Amplification and sequencing of RNA and DNA was performed using an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Viral
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Feasibility Studies

Share to Reproducibility of Results

Share to RNA, Viral

Share to Viral Load

Share to Viremia

Source

Open in PubMed Open full text

Identifiers

PMID: 17670924
DOI: 10.1128/JCM.00814-07
PMCID: PMC2045371

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots.PMID 17670924Read ↗

HIV-1 drug resistance surveillance using dried whole blood spots.Semantic proximity Read ↗

A validated in-house assay for HIV drug resistance mutation surveillance from dried blood spot specimens.Semantic proximity Read ↗

Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay.Semantic proximity Read ↗

Genotypic testing for HIV-1 drug resistance using dried blood samples.Semantic proximity Read ↗

Comparison of Plasma, Dried Blood Spots, and Peripheral Blood Mononuclear Cells as Biosamples for HIV-1 Genotypic Drug Resistance in a Tertiary Care Center.Semantic proximity Read ↗

Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.Semantic proximity Read ↗

Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistanceSemantic proximity Read ↗

HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania.Semantic proximity Read ↗

High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.Semantic proximity Read ↗

Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.Semantic proximity Read ↗

Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management.Semantic proximity Read ↗

HIV-2 Drug Resistance Genotyping from Dried Blood Spots.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.